CANF
Can-Fite BioPharma
CANF
CANF
16 hedge funds and large institutions have $953K invested in Can-Fite BioPharma in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Holders
16
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$388K | |
| 2 | +$9.32K | |
| 3 | +$1.64K | |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$217 |
| 5 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
+$42 |
Top Sellers
| 1 | -$3.36K | |
| 2 | -$2.6K | |
| 3 | -$619 | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$189 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$6 |
